Bolt Biotherapeutics
Jess Nolin is a seasoned scientist with extensive experience in biotherapeutics and cancer research. Currently serving as a Scientist at Bolt Biotherapeutics, Inc. since July 2020, Jess has previously held positions as a Senior Research Associate at Precision For Medicine and collaborated as an Independent Contractor. Prior experience includes roles at Bavarian Nordic A/S and Fred Hutchinson Cancer Research Center, where Jess contributed as a Senior Research Associate and Research Technician II, respectively. Jess began a career as a Research Associate at Xcyte Therapies after earning a Bachelor's degree in Biochemistry from Occidental College in 2001.
This person is not in the org chart
This person is not in any teams
Bolt Biotherapeutics
7 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.